局部重新进入是De Novo非典型的频繁机制
Alyssa Zaidi1, Jared Kirzner1, Christopher F Liu2
1New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, New York, USA.
JACC. Clinical electrophysiology
|December 9, 2023
概括
新的非典型心房往往是由于局部重新进入心房造成的. 复发性心房律乱可能需要重复切除,这表明潜在的渐进性心房肌病.
科学领域:
- 电子生理学 电子生理学
- 心脏病学 心脏病学
- 心脏节律失常症 心脏节律失常症
背景情况:
- 关于非典型心房的起源存在有限的数据,没有先前的切除或手术.
- 了解新的非典型的飞机制对于有效的治疗至关重要.
研究的目的:
- 报告一大群接受导管切除治疗的患者,因为他们出现了新的非典型心房动.
- 为了确定常见的心律失常机制和位置.
- 为了描述消去后的结果.
主要方法:
- 追溯收集人口统计,电生理学和结果数据.
- 对于 de novo 非典型的心房的导管切除程序.
- 对心律失常机制和位置 (左心房和右心房) 的分析.
主要成果:
- 在62名患者中确定了85种非典型飞的机制.
- 局部重新进入是一种常见的机制,特别是在右心房 (70%) 和左心房 (50%).
- 在一次切除后的66%,在多次切除后的50%,在72%的重复手术中出现了复发性心房失常.
结论:
- 新的非典型心房动经常是由局部重新进入引起的,特别是在右心房.
- 其他心房高心率往往在切除后出现,这表明潜在的渐进性心房肌病.
更多相关视频
相关概念视频
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
21
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
21
Disturbances in Heart Rhythm
970
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
970
Mechanism of Cardiac Arrhythmias
925
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
925
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
747
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
747
Cardiac Action Potential
1.5K
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
1.5K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
844
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
844


